0

    530617

    SAMPRE

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SAMPRE NUTRITIONS LTD. Share Price Today

    Investment Returns

    Over 1 Month -32.24% Over 3 Months -70.23% Over 6 Months -78.18% Over 1 Year -60.92%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SAMPRE NUTRITIONS LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 46.70
    • P/E Ratio (TTM) 12.00
    • Beta 0.40
    • Book Value / share 10.55
    • Return on equity 0.00%
    • EPS (TTM) 0.41
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 1.82
    info icon alternate text

    SAMPRE NUTRITIONS LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 15.10
    Operating Expense 15.25
    Net Profit 1.82
    Net Profit Margin (%) 12.05
    Earnings Per Share (EPS) 0.87
    EBITDA 1.57
    Effective Tax Rate (%) -250.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 7.39
    Operating Expense 6.62
    Net Profit 0.66
    Net Profit Margin (%) 8.93
    Earnings Per Share (EPS) 0.07
    EBITDA 1.52
    Effective Tax Rate (%) 13.15
    Particulars SEP 2025 (Values in Cr)
    Revenue 10.00
    Operating Expense 8.94
    Net Profit 0.89
    Net Profit Margin (%) 8.90
    Earnings Per Share (EPS) 0.41
    EBITDA 1.95
    Effective Tax Rate (%) 16.03
    Particulars JUN 2025 (Values in Cr)
    Revenue 10.87
    Operating Expense 10.18
    Net Profit 0.71
    Net Profit Margin (%) 6.53
    Earnings Per Share (EPS) 0.34
    EBITDA 1.41
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 7.77
    Operating Expense 15.07
    Net Profit -7.14
    Net Profit Margin (%) -91.89
    Earnings Per Share (EPS) -3.40
    EBITDA -5.99
    Effective Tax Rate (%) -2.14
    Particulars MAR 2026 (Values in Cr)
    Revenue 43.35
    Operating Expense 41.48
    Net Profit 3.87
    Net Profit Margin (%) 8.92
    Earnings Per Share (EPS) 1.84
    EBITDA 5.99
    Effective Tax Rate (%) -50.58
    Particulars MAR 2025 (Values in Cr)
    Revenue 25.12
    Operating Expense 32.66
    Net Profit -7.31
    Net Profit Margin (%) -29.10
    Earnings Per Share (EPS) -3.48
    EBITDA -3.36
    Effective Tax Rate (%) -2.09
    Particulars MAR 2024 (Values in Cr)
    Revenue 25.15
    Operating Expense 24.70
    Net Profit 0.31
    Net Profit Margin (%) 1.23
    Earnings Per Share (EPS) 0.43
    EBITDA 4.32
    Effective Tax Rate (%) 45.61
    Particulars MAR 2023 (Values in Cr)
    Revenue 37.11
    Operating Expense 36.76
    Net Profit 0.35
    Net Profit Margin (%) 0.94
    Earnings Per Share (EPS) 0.61
    EBITDA 4.13
    Effective Tax Rate (%) 16.66
    Particulars MAR 2022 (Values in Cr)
    Revenue 23.13
    Operating Expense 23.03
    Net Profit 0.31
    Net Profit Margin (%) 1.34
    Earnings Per Share (EPS) 0.64
    EBITDA 3.77
    Effective Tax Rate (%) 16.21
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 42.44
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.30
    EBITDA Margin -13.85
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 26.75
    ROE % 1.05
    ROCE % 6.19
    Total Debt to Total Equity 0.79
    EBITDA Margin 16.86
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 27.39
    ROE % 1.65
    ROCE % 6.09
    Total Debt to Total Equity 0.79
    EBITDA Margin 11.13
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 38.14
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.30
    EBITDA Margin -13.38
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 28.29
    ROE % 1.42
    ROCE % 6.39
    Total Debt to Total Equity 0.78
    EBITDA Margin 17.18
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 27.39
    ROE % 2.17
    ROCE % 6.58
    Total Debt to Total Equity 1.18
    EBITDA Margin 11.13
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 23.01
    ROE % 2.83
    ROCE % 6.65
    Total Debt to Total Equity 1.94
    EBITDA Margin 16.34
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 22.37
    ROE % 0.74
    ROCE % 5.25
    Total Debt to Total Equity 1.93
    EBITDA Margin 18.98
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.23
    Total Assets 115.43
    Total Liabilities 115.43
    Total Equity 90.87
    Share Outstanding 2
    Price to Book Ratio 0.59
    Return on Assets (%) -6.64
    Return on Capital (%) -7.12
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.28
    Total Assets 44.75
    Total Liabilities 44.75
    Total Equity 22.46
    Share Outstanding 0
    Price to Book Ratio 2.41
    Return on Assets (%) 0.51
    Return on Capital (%) 0.58
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 43.58
    Total Liabilities 43.58
    Total Equity 21.15
    Share Outstanding 0
    Price to Book Ratio 3.33
    Return on Assets (%) 0.79
    Return on Capital (%) 0.92
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 117.07
    Total Liabilities 117.07
    Total Equity 92.56
    Share Outstanding 2
    Price to Book Ratio 0.59
    Return on Assets (%) -6.24
    Return on Capital (%) -6.68
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.10
    Total Assets 44.83
    Total Liabilities 44.83
    Total Equity 22.54
    Share Outstanding 0
    Price to Book Ratio 2.41
    Return on Assets (%) 0.69
    Return on Capital (%) 0.77
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 43.58
    Total Liabilities 43.58
    Total Equity 21.15
    Share Outstanding 0
    Price to Book Ratio 3.33
    Return on Assets (%) 0.79
    Return on Capital (%) 0.92
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 37.70
    Total Liabilities 37.70
    Total Equity 11.09
    Share Outstanding 0
    Price to Book Ratio 1.41
    Return on Assets (%) 0.81
    Return on Capital (%) 0.95
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 38.28
    Total Liabilities 38.28
    Total Equity 10.78
    Share Outstanding 0
    Price to Book Ratio 0.65
    Return on Assets (%) 0.19
    Return on Capital (%) 0.24
    Particulars MAR 2025 (Values in Cr)
    Net Income -7.52
    Cash from Operations 0.19
    Cash from Investing -75.16
    Cash from Financing 75.02
    Net change in Cash -0.05
    Free Cash Flow 0.46
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.48
    Cash from Operations 3.73
    Cash from Investing -3.69
    Cash from Financing -0.09
    Net change in Cash 0.15
    Free Cash Flow 7.44
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.41
    Cash from Operations 1.13
    Cash from Investing -4.31
    Cash from Financing 3.48
    Net change in Cash 0.04
    Free Cash Flow 5.54
    Particulars MAR 2025 (Values in Cr)
    Net Income -7.16
    Cash from Operations 0.19
    Cash from Investing -75.16
    Cash from Financing 75.02
    Net change in Cash -0.05
    Free Cash Flow 0.47
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.56
    Cash from Operations 3.81
    Cash from Investing -3.95
    Cash from Financing -0.09
    Net change in Cash -0.01
    Free Cash Flow 7.52
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.41
    Cash from Operations 1.13
    Cash from Investing -4.31
    Cash from Financing 3.48
    Net change in Cash 0.04
    Free Cash Flow 5.54
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.37
    Cash from Operations 2.72
    Cash from Investing -0.76
    Cash from Financing -1.65
    Net change in Cash -0.01
    Free Cash Flow 4.03
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.10
    Cash from Operations 0.02
    Cash from Investing -0.89
    Cash from Financing 0.32
    Net change in Cash -0.75
    Free Cash Flow 2.38
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD 5521.55 52.52 26.04 132996.63 5038.00 6336.95
    NESTLE INDIA LTD. 1520.50 79.11 56.85 293200.19 1085.00 1532.50
    FOODS & INNS LTD. 54.16 14.37 0.70 398.25 45.00 112.00
    HINDUSTAN UNILEVER LTD. 2108.05 44.92 10.16 495305.59 2019.00 2734.31
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD 5521.55 51.94 28.65 132996.63 5038.00 6336.95
    COLGATE PALMOLIVE LTD. 2084.90 41.42 35.79 56706.28 1781.60 2505.00
    NESTLE INDIA LTD. 1520.50 78.09 55.22 293200.19 1085.00 1532.50
    FOODS & INNS LTD. 54.16 12.71 0.69 398.25 45.00 112.00

    SAMPRE NUTRITIONS LTD. shareholding pattern

    Holding
    85.96%
    14.03%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    SAMPRE NUTRITIONS LTD. Technicals Summary

    4.92 -4.83 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 5.40
    • 26 Days 7.00
    • 10 Days 5.90
    • 50 Days 8.90
    • 12 Days 6.00
    • 100 Days 12.40
    • 20 Days 6.50
    • 200 Days 15.90
    5.28 PIVOT
    First Support 5.06 First Resistance 5.39 Second Support 4.95 Second Resistance 5.61 Third Support 4.73 Third Resistance 5.72
    RSI 25.33 ADX 27.07 MACD -0.92 Williams % R -100.00 Commodity Channel Index (CCI) -162.33
    Date 2026-07-30 Week 210344.00 Same Day 173164.00 Month 276374.00
    1 Year 0.41 3 Year 0.33
    Over 1 Month
    -32.24% down
    Over 1 Year
    -60.92% down
    Over 3 Months
    -70.23% down
    Over 3 Years
    -30.97% down
    Over 6 Months
    -78.18% down
    Over 5 Years
    4.95% down

    SAMPRE NUTRITIONS LTD. Corporate Actions

    Ex-Date Ex-Bonus Ratio
    14 Nov 2025 14 Nov 2025 1:1
    Ex-Date Old FV NEW FV Record Date
    14 Nov 2025 10.0 5.0 14 Nov 2025

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Sampre Nutritions Ltd?

    Answer Field

    Sampre Nutritions Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 4.92 as on Jul 31 2026 03:30 PM.

    What is the Market Cap of Sampre Nutritions Ltd Share?

    Answer Field

    The market cap of Sampre Nutritions Ltd for NSE ₹ 0.00 & for BSE ₹ 46.70 as on Jul 31 2026 03:30 PM.

    What is the 52 Week High and Low of Sampre Nutritions Ltd?

    Answer Field

    The 52 Week High and Low of Sampre Nutritions Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 42.33 and ₹ 4.92.

    What is 1 year return for Sampre Nutritions Ltd?

    Answer Field

    The 1 year returns on the stock has been -63.55%.

    What is the P/E Ratio of Sampre Nutritions Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM the price-to-earnings (PE) ratio for Sampre Nutritions Ltd share is 12.00.

    What is the PB ratio of Sampre Nutritions Ltd Share?

    Answer Field

    As on Jul 31 2026 03:30 PM, the price-to-book (PB) ratio for Sampre Nutritions Ltd share is 10.55.

    How to Buy Sampre Nutritions Ltd Share?

    Answer Field

    You can trade in Sampre Nutritions Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Sampre Nutritions Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Sampre Nutritions Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Sampre Nutritions Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |